Glycoxydation promotes vascular damage Via MAPK-ERK/JNK pathways
Oxidation and glycation enhance foam cell formation via MAPK/JNK in euglycemic and diabetic subjects. Here, we investigated the effects of glycated and oxidized LDL (glc‐oxLDL) on MAPK‐ERK and JNK signaling pathways using human coronary smooth muscle cells. Glc‐oxLDL induced a broad cascade of MAPK/...
Saved in:
Published in | Journal of cellular physiology Vol. 227; no. 11; pp. 3639 - 3647 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.11.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Oxidation and glycation enhance foam cell formation via MAPK/JNK in euglycemic and diabetic subjects. Here, we investigated the effects of glycated and oxidized LDL (glc‐oxLDL) on MAPK‐ERK and JNK signaling pathways using human coronary smooth muscle cells. Glc‐oxLDL induced a broad cascade of MAPK/JNK‐dependent signaling transduction pathways and the AP‐1 complex. In glc‐oxLDL treated coronary arterioles, tumor necrosis factor (TNF) α increased JNK phosphorylation, whereas protein kinase inhibitor dimethylaminopurine (DMAP) prevented the TNF‐induced increase in JNK phosphorylation. The role of MKK4 and JNK were then investigated in vivo, using apolipoprotein E knockout (ApoE−/−) mice. Peritoneal macrophages, isolated from spontaneously hyperlipidemic but euglycemic mice showed increases in both proteins and phosphorylated proteins. Compared to streptozotocin‐treated diabetic C57BL6 and nondiabetic C57BL6 Wt mice, in streptozotocin‐diabetic ApoE−/− mice, the increment of foam cell formation corresponded to an increment of phosphorylation of JNK1, JNK2, and MMK4. Thus, we provide a first line of evidence that MAPK‐ERK/JNK pathways are involved in vascular damage induced by glycoxidation. J. Cell. Physiol. 227: 3639–3647, 2012. © 2012 Wiley Periodicals, Inc. |
---|---|
Bibliography: | PRIN 2008 Foundation Jerome Lejeune ark:/67375/WNG-J0HP34FN-K NIH HL-089559 Ellisson Medical Foundation Award AG-SS 1851-07 istex:46BB7A494539DEDEE610A7D2ED80904EC18AD957 Conflicts of interests: The authors have no conflicts of interests in the connection of this study. ArticleID:JCP24070 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0021-9541 1097-4652 1097-4652 |
DOI: | 10.1002/jcp.24070 |